Enhanced Luminescence-based Method for Precise Delivery of Ion Beam Therapy

Publication ID: 24-11857806_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Luminescence-based Method for Precise Delivery of Ion Beam Therapy,” Published Technical Disclosure No. 24-11857806_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857806_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,806.

Summary of the Inventive Concept

An improved method for precise delivery of ion beam therapy, utilizing advanced luminescence-based markers and real-time tracking to minimize radiation damage and enhance treatment accuracy.

Background and Problem Solved

Conventional radiation therapy methods often result in unwanted radiation exposure to surrounding tissue. The original patent, 'Luminescence-based method for precise delivery of ion beam therapy', addressed this issue by using an EUD4TEA-inclusive marker to track ion beam delivery. However, the original method had limitations in terms of radiation damage to surrounding tissue and accuracy of ion beam delivery. The new inventive concept builds upon the original patent by introducing optimized markers, real-time tracking, and dynamic ion beam intensity adjustment to further minimize radiation damage and enhance treatment accuracy.

Detailed Description of the Inventive Concept

The new inventive concept comprises a system for precise delivery of ion beam therapy, featuring a luminescence-based marker optimized for reduced radiation damage to surrounding tissue. The marker is designed to track ion beam delivery in real-time, allowing for dynamic adjustment of the ion beam trajectory and intensity. The system includes a novel triboluminescent material that emits light in response to ion beam impingement, which is detected by a sensor. This enables real-time monitoring of ion beam therapy and ensures accurate treatment. The inventive concept also encompasses methods for enhancing the accuracy of ion beam therapy, reducing radiation exposure, and providing real-time monitoring of ion beam therapy.

Novelty and Inventive Step

The new inventive concept introduces several novel and non-obvious features compared to the original patent, including optimized luminescence-based markers, real-time tracking, and dynamic ion beam intensity adjustment. These advancements enable more precise and efficient ion beam therapy, while minimizing radiation damage to surrounding tissue.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different luminescent materials, varying marker designs, or alternative detection methods. Additionally, the inventive concept could be adapted for use in other forms of radiation therapy, such as gamma knife therapy or proton therapy.

Potential Commercial Applications and Market

The enhanced luminescence-based method for precise delivery of ion beam therapy has significant commercial potential in the radiation oncology market, with potential applications in cancer treatment centers, hospitals, and research institutions. The inventive concept's ability to minimize radiation damage and enhance treatment accuracy makes it an attractive solution for healthcare providers seeking to improve patient outcomes.

Original Patent Information

Patent NumberUS 11,857,806
TitleLuminescence-based method for precise delivery of ion beam therapy
Assignee(s)United States of America as represented by the Secretary of the Navy